Online Publication Date:
28 Dec 2018
JAMA study finds better health outcomes and lower mortality rate for undocumented immigrants with scheduled dialysis

JAMA Internal Medicine published findings this month that found when “compared with emergency-only dialysis, scheduled dialysis significantly reduced 1-year mortality, hospitalizations, and costs among undocumented immigrants with end-stage renal disease (ESRD). However, in “40 of 50 US states, scheduled dialysis is withheld from undocumented immigrants with ESRD; instead, they receive intermittent emergency-only dialysis to treat life-threatening manifestations of ESRD’”.
By:
ASN Staff
Search for other papers by ASN Staff in
Current site
Google Scholar
PubMed Close

JAMA Internal Medicine published findings this month that found when “compared with emergency-only dialysis, scheduled dialysis significantly reduced 1-year mortality, hospitalizations, and costs among undocumented immigrants with end-stage renal disease (ESRD). However, in “40 of 50 US states, scheduled dialysis is withheld from undocumented immigrants with ESRD; instead, they receive intermittent emergency-only dialysis to treat life-threatening manifestations of ESRD’”.

In the “cohort study of 181 adults, individuals receiving scheduled vs emergency-only dialysis has a 1-year mortality rate of 3% vs 17%, 6 fewer emergency department visits per month, 1.5 fewer hospitalizations, 10 fewer hospital days per 6 months, and incurred $5,768 less in health care costs per month”. The findings show that due to the numerous benefits financially and in health outcomes, scheduled dialysis “should be the universal standard of care for all individuals with ESRD in the United States”.

Save